TFP
HZNP

Tilia Fiduciary Partners’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Tilia Fiduciary Partners’s Portfolio HZNP Stock Details HZNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-202
Closed -$13K – 537
2022
Q3 		$13K Hold
202
– – 0.01% 349
2022
Q2 		$16K Hold
202
– – 0.02% 340
2022
Q1 		$21K Hold
202
– – 0.02% 318
2021
Q4 		$22K Buy
+202
New +$22K 0.02% 325

Other funds holding HZNP

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Tilia Fiduciary Partners's HZNP Position: Q4 2022 in Review

Tilia Fiduciary Partners sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q4 2022, closing a stake of 202 shares — an estimated $13K sold.

Tilia Fiduciary Partners first reported a position in HZNP in Q4 2021 and held it in 4 quarters. The position peaked at $22K in Q4 2021. 615 funds tracked by Wall St. Rank hold HZNP as of Q4 2022.

  • Tilia Fiduciary Partners reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q4 2022 after selling out during the quarter.
  • Tilia Fiduciary Partners sold 202 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2022, an estimated $13K.
  • Tilia Fiduciary Partners first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2021 and held it in 4 quarters.
  • Tilia Fiduciary Partners's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $22K in Q4 2021.
  • 615 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2022.

Based on Tilia Fiduciary Partners's 13F filing for Q4 2022, filed 10 Feb 2023.